|
|
- cas：1476-53-5
- 发布日期： 2014-06-05
- 更新日期： 2023-04-24
| 英文名称 | NOVOBIOCIN SODIUM SALT |
| 纯度 | % |
| CAS编号 | 1476-53-5 |
| 别名 | 新生霉素钠盐90% |
| 分子式 | C31H35N2NaO11 |
|
新生霉素 |
1476-53-5 |
BR，90% |
1克 |
280 |
2～8℃ |
||
|
中文名称: |
氧乐果-D6 |
||||||
|
中文同义词: |
新生霉素一钠盐;氧乐果-D6;新生霉素钠;新生霉素氯化钠;新生霉素钠盐90%;新生霉素纳;新生霉素钠盐(+4℃);新生霉素钠盐 |
||||||
|
英文名称: |
NOVOBIOCIN SODIUM SALT |
||||||
|
英文同义词: |
albamycin(capsule);Albamycinsodium;Cathomycinsodium;Cathomycinsodiumlyovac;Monosodiumnovobiocin;Novobiocin,sodiumderiv.;Novobiocinmonosodium;Sodiumalbamycin |
||||||
|
CAS号: |
|||||||
|
分子式: |
C31H35N2NaO11 |
||||||
|
分子量: |
634.61 |
||||||
|
EINECS号: |
216-023-6 |
||||||
|
Mol文件: |
1476-53-5.mol |
||||||
对临床上常用的一些抗癌药还有调节作用，既能增强新生霉素某些抗癌药的作用，也能降低某些抗癌药的作用。新生霉素是拓扑异构酶的抑制剂，对癌细胞的生长和增殖具有很大的影响，同时能使癌细胞对抗癌药的敏感性增加。Kennedy等的研究对38例伴有转移的乳腺癌患者进行新生霉素和多种烷化剂(如CTX、塞替派)联合治疗，每天用0.5～5gNOVO口服，连续7d
Some cancer drugs and regulating role of clinical commonly used, can not only enhance the effect of novobiocin certain cancer drugs,
can reduce the effect of certain cancer drugs. Novobiocin is an inhibitor of topoisomerase has a great influence on cancer cell growth
and proliferation, and at the same time can increase the sensitivity of cancer cells to anticancer drugs. Kennedy, such as the study of
38 patients with metastasis of breast cancer patients who were novobiocin and a variety of alkylating agent (CTX, plug for pie) combination
therapy, with 0.5 ~ 5 gnovo oral every
